Application of CIGB-128 in keloid patients undergoing surgical exeresis. |
2010-12-24 |
CIGB |
InCarbacel-II |
2010-12-28 |
CIGB |
Recombinant interferon alpha-2b in paranoid schizophrenia. |
2009-02-11 |
CIGB |
Recombinant IFN alpha-2b for relapsing –remitting multiple sclerosis. |
2009-02-11 |
CIGB |
Diphenhydramine previous to CIGB-300 in cervical carcinoma (CERVISEG-II Study) |
2013-05-16 |
CIGB |
Study in Hematological Malignancies |
14/11/2014 |
CIGB |
Phase I with CIGB-814 in rheumatoid arthritis patients |
16/02/2017 |
CIGB |
Retrospective observational study of the administration of Jusvinza, for the management of COVID-19 at the Hospital “Dr. Luis Diaz Soto”. |
29/10/2021 |
CIGB |
CIGB-370 in patients with malignant tumors |
01/02/2016 |
CIGB |
DENIS Study |
22/10/2018 |
CIGB |
CIGB-258 at COVID-19 |
14/05/2020 |
CIGB |
OLIVO Study |
01/10/2020 |
CIGB |
ABDALA Clinical Study - Phase III |
18/03/2021 |
CIGB |
Jusvinza in adult patients with Rheumatoid Arthritis from Camaguey and Eastern Provinces |
27/02/2024 |
CIGB_IB |
T1h in severe psoriasis-expanded access program (PUCE) |
2012-07-20 |
CIM |
1E10 anti-idiotype vaccine, metastatic colon, phase II. |
2010-12-03 |
CIM |
Toxicological evaluation of the humanized Anti-CD6 MAb T1h in Rheumatoid Arthritis Patients |
2010-12-24 |
CIM |
1E10 anti-idiotype vaccine, metastatic breast cancer, phase II |
2010-12-27 |
CIM |
Anti-idiotype 1E10 vaccine in advanced non- small cell lung (NSCLC) patients |
2010-12-28 |
CIM |
Anti-idiotype 1E10 vaccine in the treatment of patients with small cell lung (SCLC) patients |
2010-12-28 |
CIM |